Zhengguang shares rose by more than 10%, and Xinjiang Bai Hua Cun Pharma Tech, Brightgene Bio-Medical Technology Co.,Ltd., Novartis AG, Shengnuo Biotechnology Co., Ltd., Shanghai Medicilon Inc. and Dezhan Healthcare followed suit. In terms of news, both the top two weight-loss drugs in the US stock market hit historical highs, with Novo-Nordisk A/S up 3.25% to $146.91 and Eli Lilly and Co up 1.63% to $904.61.
减肥药概念股开盘拉升 争光股份涨超10%
Weight loss concept stocks opened higher, and Zhengguang shares rose more than 10%. Xinjiang Bai Hua Cun Pharma Tech, Brightgene Bio-Medical Technology Co.,Ltd., Novartis AG, Shengnuo Biotechnology Co., Ltd., Shanghai Medicilon Inc. and Dezhan Healthcare
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.